PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Sharewise Presentation 22/7/24, page-15

  1. 1,282 Posts.
    lightbulb Created with Sketch. 256
    If they get FDA approval for stage 3 it won't be 30c that's for sure.
    The current price reflects all the uncertainty because people will pay a lot more knowing that they're likely to get a partnership ( if you believe PR ) & there is a path to the endpoint.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.